Deep search
Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
    • Hotels
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
  • Past hour
    • Any time
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Most recent
    • Best match

News

Pharmabiz
58m
Tyra Biosciences begins patient dosing in phase 2 study of TYRA-300 in low-grade intermediate risk non-muscle invasive bladder cancer
Carlsbad, California Tuesday, July 1, 2025, 16:00 Hrs [IST] ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Trending now

Kohberger accepts plea deal
Confirm settlement talks
Man sentenced for stabbing
Health care fraud takedown
Israel strikes cafe in Gaza
Storm Flossie strengthens
To hear MI pipeline case
Home Depot to buy GMS
Announces run for governor
Takes down NK IT scheme
Throws out appellate rulings
SCOTUS rejects appeal
Thai court suspends PM
Boulder attack victim dies
Says he won't seek reelection
Declines free speech appeal
Ex-NFL DT Gibson dies
Lululemon sues Costco
Morphew extradited to CO
Trump lifts Syria sanctions
Trump to host Netanyahu
Bacon won't seek reelection
Face checks for CA users
Ex-executive subpoenaed
Federal judge seeks clarity
Trump admin appeals ruling
Officer dies in line of duty
Hit with cyberattack
Apple antitrust case stays
Feedback
© 2025 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices
  • Consumer Health Privacy